Abstract

A mass vaccination campaign in India seeks to control and eventually eradicate foot-and-mouth disease (FMD). Biosanitary measures along with FMD monitoring are being conducted along with vaccination. The implementation of the FMD control program has drastically reduced the incidence of FMD. However, cases are still reported, even in regions where vaccination is carried out regularly. Control of FMD outbreaks is difficult when the virus remains in circulation in the vaccinated population. Various FMD risk factors have been identified that are responsible for FMD in vaccinated areas. The factors are discussed along with strategies to address these challenges. The current chemically inactivated trivalent vaccine formulation containing strains of serotype O, A, and Asia 1 has limitations including thermolability and induction of only short-term immunity. Advantages and disadvantages of several new-generation alternate vaccine formulations are discussed. It is unfeasible to study every incidence of FMD in vaccinated animals/areas in such a big country as India with its huge livestock population. However, at the same time, it is absolutely necessary to identify the precise reason for vaccination failure. Failure to vaccinate is one reason for the occurrence of FMD in vaccinated areas. FMD epidemiology, emerging and re-emerging virus strains, and serological status over the past 10 years are discussed to understand the impact of vaccination and incidences of vaccination failure in India. Other factors that are important in vaccination failure that we discuss include disrupted herd immunity, health status of animals, FMD carrier status, and FMD prevalence in other species. Recommendations to boost the search of alternate vaccine formulation, strengthen the veterinary infrastructure, bolster the real-time monitoring of FMD, as well as a detailed investigation and documentation of every case of vaccination failure are provided with the goal of refining the control program.

Highlights

  • Foot-and-mouth disease (FMD) is a highly contagious and economically important disease of cloven-hoofed domestic and wild ruminants including cattle, buffalo, swine, goats, and sheep [1,2].High body temperature and appearance of vesicular lesions on oro-nasal mucosa, interdigital cleft, coronary band, udder, and teats epithelium are primary characteristics of the disease

  • Successful control and eradication of the disease in these countries using inactivated vaccines is well documented and available for other countries to follow the progressive control of the disease as envisaged in the progressive control pathway (PCP) pathway

  • FMD control program (FMDCP) was initiated in India in the year 2003

Read more

Summary

Introduction

Foot-and-mouth disease (FMD) is a highly contagious and economically important disease of cloven-hoofed domestic and wild ruminants including cattle, buffalo, swine, goats, and sheep [1,2]. Epidemiological complexity, increasing movement of animals and animal products in the international market, high infectivity rate, emergence of new variants, interface of domestic and wild animals, lack of highly potent vaccines, and lack of required infrastructure are some of the key factors that hinder the control and the eradication of FMD in endemic settings [18]. The details of both conventional and new-generation advances in FMDV vaccine design and formulation are discussed from the perspective of the use in India. It is crucially important to understand the advantages and the disadvantages of new-generation and conventional FMD vaccines, the details of the epidemiology of FMD in India, and the limiting factors accounting for vaccine failures and design of strategies to counter failures and strengthen the available infrastructure in India to implement an effective FMD prevention and control program

Trends and Advances in Vaccines against FMDV
Inactivated Whole Virus Vaccines
Modified Virus Inactivated Vaccines
Live Attenuated Vaccines
Viral Vector Vaccines
Virus-Like Particle Vaccines
DNA Vaccines
Peptide Vaccines
Plant Based Recombinant Vaccines
Potential Use of Immunomodulatory Molecules
Epidemiology of FMD in India
Circulating Virus Pool
Serotype O
Serotype A
Serotype Asia 1
FMD Monitoring in India
Immunobiology of FMDV and Vaccine Failures
Failure to Vaccinate
Vaccination Failure
Vaccine Strain Matching with Circulating Virus
Vaccine Quality
Impaired Immune Response to Vaccine
Break in the Herd Immunity
Duration of Protective Immunity
Maternally Derived Antibody Inhibition
FMDV Persistence in Recovered Animals
Other Factors
Tackling the Challenges
Findings
Conclusions and Future Prospects

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.